Wikipedia -WSS

Wikipedia

author：focus 2025-09-06 05:03:09 - browse：12

a liver made up by geometric shapes – biotech coverage from STAT — Adobe

LONDON — A drug in development as a weight loss treatment succeeded in a Phase 2 study in a serious liver condition, its developers said Monday, as the competition in the broader obesity medicine field pushes ahead.

The drug, survodutide, is being developed by the privately held German firm Boehringer Ingelheim and the Danish biotech Zealand Pharma. Zealand’s share price has doubled over the past year over the potential of the drug, and on Monday morning, shares jumped another 25%.

In the study, 83% of patients with a condition called MASH and who were treated with survodutide saw significant improvements in their disease compared to 18% of those who received placebo. The study met its primary endpoint of improvements in MASH after 48 weeks without the worsening of fibrosis, a scarring of the liver, the companies said. Secondary endpoints were also met, including an improvement in fibrosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Shifting the focus from loneliness to social health

leisure time

WSS

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

Innovation in antibiotics is ailing. 'Brain drain' may kill it

Letters to First Opinion on caregivers, digital health, and more

National associations that represent hospice owe an apology

Meadows told special counsel he could not recall Trump ever declassifying Mar

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

focus

Wikipedia

hotspot

Jerome Adams on the need for new antivirals for Covid

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Hospital at home shows how to bring innovation to health care

Duchenne breakthrough therapy leaves behind pioneering families

Kellogg’s is going to war over Mexico’s nutrition label rules

Continuity nursing helped my family in our darkest PICU moments

At ASCO, AstraZeneca reports strong data for breast cancer drug

Heart attack and stroke risk calculators need revising

Ionis drug prevents swelling attacks due to hereditary angioedema

leisure time

Meadows told special counsel he could not recall Trump ever declassifying Mar

Wegovy improves function in certain heart failure patients

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

Health officials lay out plans to cope with respiratory virus season

How to make over

DeSantis wants to import drugs. Biden’s FDA blasted his plan

knowledge

leisure time

leisure time

explore